Toon Van Gorp, MD, PhD, discussed findings from the MIRASOL trial and the potential of mirvetuximab to redefine treatment ...
12h
CET, Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, announces the signing of a letter of intent (LOI) for the ...
Communiqué de la société OXURION du 18/03/2025 - Oxurion signs a letter of intent for the planned acquisition of a biometrics-focused CRO ...
Mirvetuximab soravtansine improved overall survival over chemotherapy in patients with FRα-positive, platinum-resistant ovarian cancer.
NORTH CHICAGO, IL, USA I March 15, 2025 I AbbVie (NYSE: ABBV) today announced the final analysis of the confirmatory Phase 3 MIRASOL trial evaluating the ...
The Belgian capital is renowned across the world as the centre of European politics. There are over 2,250 international ...
This year’s edition, from 13 to 23 March, you can enjoy more than 45 events spread all over the city ... Whether you're a jazz aficionado or just looking for a great night out, Leuven Jazz welcomes ...
First-ever global no-alcohol beer partnership in WSL history will enhance moments of relaxation and celebration for athletes and fans LISBON, Portugal -- (BUSINESS WIRE) -- Today, Corona Cero, the ...
AbbVie (NYSE: ABBV) today announced the final analysis of the confirmatory Phase 3 MIRASOL trial evaluating the efficacy and safety of ELAHERE� (mirvetuximab soravtansine-gynx) in women with folate ...
Far beyond the eight familiar planets in our solar system, countless bizarre and extreme worlds await discovery — and some ...
Filgotinib, a Janus Kinase 1 inhibitor, remains well-tolerated for up to 8 years with consistent efficacy in patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback